| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine/serine/threonine phosphatase activity | 7.61e-05 | 43 | 105 | 4 | GO:0008138 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential | 8.19e-05 | 3 | 105 | 2 | GO:0150047 | |
| GeneOntologyMolecularFunction | IMP 5'-nucleotidase activity | 1.63e-04 | 4 | 105 | 2 | GO:0050483 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 1.63e-04 | 4 | 105 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 1.63e-04 | 4 | 105 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 1.63e-04 | 4 | 105 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 1.63e-04 | 4 | 105 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.02e-04 | 22 | 105 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.81e-04 | 60 | 105 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 4.05e-04 | 6 | 105 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 4.05e-04 | 6 | 105 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.31e-04 | 120 | 105 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRD GJD2 KCNV2 PKD2L1 GJC2 GRIN2B P2RX4 APOL4 UNC80 | 4.48e-04 | 525 | 105 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRD GJD2 KCNV2 PKD2L1 GJC2 GRIN2B P2RX4 APOL4 UNC80 | 4.54e-04 | 526 | 105 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 6.59e-04 | 75 | 105 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 7.28e-04 | 77 | 105 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | phosphatase activity | 8.08e-04 | 287 | 105 | 7 | GO:0016791 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.05e-03 | 85 | 105 | 4 | GO:0017018 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 1.20e-03 | 10 | 105 | 2 | GO:0033550 | |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 1.46e-03 | 11 | 105 | 2 | GO:0008330 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.92e-03 | 100 | 105 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 DCHS2 FAT3 PCDHB13 PCDHB12 RCN2 CDH23 PKD2L1 PLA2G4D CDH22 CDH18 | 1.95e-03 | 749 | 105 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 2.06e-03 | 13 | 105 | 2 | GO:0099528 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 2.06e-03 | 13 | 105 | 2 | GO:0017017 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.10e-03 | 339 | 105 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 2.14e-03 | 103 | 105 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 2.63e-03 | 109 | 105 | 4 | GO:0004722 | |
| GeneOntologyMolecularFunction | 5'-nucleotidase activity | 2.75e-03 | 15 | 105 | 2 | GO:0008253 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.93e-03 | 459 | 105 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 3.24e-03 | 189 | 105 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.36e-03 | 57 | 105 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | CDC14C XRN2 DUSP4 DUSP5 ACOT1 PLA2G4D CDC14B NT5C NT5C1A MTM1 PGBD5 | 3.46e-03 | 807 | 105 | 11 | GO:0016788 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.55e-03 | 193 | 105 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.62e-03 | 194 | 105 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.87e-03 | 197 | 105 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | nucleotidase activity | 3.97e-03 | 18 | 105 | 2 | GO:0008252 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 3.97e-03 | 18 | 105 | 2 | GO:0033549 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 4.30e-03 | 386 | 105 | 7 | GO:0042578 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.33e-03 | 599 | 105 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.42e-03 | 19 | 105 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 4.42e-03 | 19 | 105 | 2 | GO:0032794 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.87e-03 | 65 | 105 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.87e-03 | 65 | 105 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | proteasome binding | 4.89e-03 | 20 | 105 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.39e-03 | 21 | 105 | 2 | GO:0042975 | |
| GeneOntologyCellularComponent | catenin complex | 1.87e-05 | 32 | 104 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.49e-04 | 21 | 104 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 TRIM15 GJD2 PKP4 NOX4 GJC2 DES CDH22 PIK3R2 PI4KA CSPG4 KAZN CTNNA1 CDH18 | 3.38e-04 | 976 | 104 | 14 | GO:0070161 |
| MousePheno | abnormal learning/memory/conditioning | GABRB1 CDC14C GABRD CHST5 RELCH GJD2 KDM3B CDH23 GJC2 ACOT1 NDN GRIN2B CDC14B OPA1 NCOR1 THOP1 LZTS1 ICAM5 AUTS2 UNC80 PGBD5 GABBR1 CDH18 CA8 | 5.09e-07 | 1239 | 89 | 24 | MP:0002063 |
| MousePheno | abnormal cognition | GABRB1 CDC14C GABRD CHST5 RELCH GJD2 KDM3B CDH23 GJC2 ACOT1 NDN GRIN2B CDC14B OPA1 NCOR1 THOP1 LZTS1 ICAM5 AUTS2 UNC80 PGBD5 GABBR1 CDH18 CA8 | 5.64e-07 | 1246 | 89 | 24 | MP:0014114 |
| Domain | Cadherin_CS | 2.08e-06 | 109 | 101 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 2.65e-06 | 113 | 101 | 7 | PS00232 | |
| Domain | Cadherin | 2.65e-06 | 113 | 101 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 2.81e-06 | 114 | 101 | 7 | PS50268 | |
| Domain | - | 2.81e-06 | 114 | 101 | 7 | 2.60.40.60 | |
| Domain | CA | 2.98e-06 | 115 | 101 | 7 | SM00112 | |
| Domain | Cadherin-like | 3.16e-06 | 116 | 101 | 7 | IPR015919 | |
| Domain | Cadherin | 3.54e-06 | 118 | 101 | 7 | IPR002126 | |
| Domain | HEAT_type_2 | 9.88e-05 | 17 | 101 | 3 | IPR021133 | |
| Domain | PTPc_motif | 2.92e-04 | 59 | 101 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.92e-04 | 59 | 101 | 4 | IPR003595 | |
| Domain | HEAT_REPEAT | 5.62e-04 | 70 | 101 | 4 | PS50077 | |
| Domain | Filament_head | 5.97e-04 | 7 | 101 | 2 | PF04732 | |
| Domain | CULLIN | 5.97e-04 | 7 | 101 | 2 | SM00182 | |
| Domain | Intermed_filament_DNA-bd | 5.97e-04 | 7 | 101 | 2 | IPR006821 | |
| Domain | Tyr_Pase_AS | 6.59e-04 | 73 | 101 | 4 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_DUAL | 8.13e-04 | 34 | 101 | 3 | PS50054 | |
| Domain | TYR_PHOSPHATASE_DUAL_dom | 8.86e-04 | 35 | 101 | 3 | IPR020422 | |
| Domain | DSPc | 8.86e-04 | 35 | 101 | 3 | SM00195 | |
| Domain | Cullin_homology | 1.02e-03 | 9 | 101 | 2 | IPR016158 | |
| Domain | TYR_PHOSPHATASE_1 | 1.22e-03 | 86 | 101 | 4 | PS00383 | |
| Domain | MKP | 1.27e-03 | 10 | 101 | 2 | IPR008343 | |
| Domain | Cullin | 1.27e-03 | 10 | 101 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.27e-03 | 10 | 101 | 2 | PS50069 | |
| Domain | Cullin_N | 1.27e-03 | 10 | 101 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 1.27e-03 | 10 | 101 | 2 | PS01256 | |
| Domain | TYR_PHOSPHATASE_2 | 1.27e-03 | 87 | 101 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.27e-03 | 87 | 101 | 4 | IPR000387 | |
| Domain | - | 1.31e-03 | 222 | 101 | 6 | 1.25.10.10 | |
| Domain | Rho_GTPase_activation_prot | 1.33e-03 | 88 | 101 | 4 | IPR008936 | |
| Domain | Dual-sp_phosphatase_cat-dom | 1.41e-03 | 41 | 101 | 3 | IPR000340 | |
| Domain | DSPc | 1.41e-03 | 41 | 101 | 3 | PF00782 | |
| Domain | - | 1.56e-03 | 92 | 101 | 4 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.05e-03 | 99 | 101 | 4 | IPR029021 | |
| Domain | ARM-type_fold | 2.44e-03 | 339 | 101 | 7 | IPR016024 | |
| Domain | ARM-like | 3.48e-03 | 270 | 101 | 6 | IPR011989 | |
| Domain | HEAT | 3.82e-03 | 58 | 101 | 3 | IPR000357 | |
| Domain | RhoGAP | 4.61e-03 | 62 | 101 | 3 | SM00324 | |
| Domain | CONNEXINS_1 | 4.66e-03 | 19 | 101 | 2 | PS00407 | |
| Domain | RhoGAP | 4.82e-03 | 63 | 101 | 3 | PF00620 | |
| Domain | RHOGAP | 5.04e-03 | 64 | 101 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 5.04e-03 | 64 | 101 | 3 | IPR000198 | |
| Domain | - | 5.04e-03 | 64 | 101 | 3 | 1.10.555.10 | |
| Domain | CONNEXINS_2 | 5.16e-03 | 20 | 101 | 2 | PS00408 | |
| Domain | Connexin | 5.16e-03 | 20 | 101 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 5.16e-03 | 20 | 101 | 2 | IPR019570 | |
| Domain | Connexin_N | 5.16e-03 | 20 | 101 | 2 | IPR013092 | |
| Domain | Connexin | 5.16e-03 | 20 | 101 | 2 | PF00029 | |
| Domain | Connexin_CCC | 5.16e-03 | 20 | 101 | 2 | SM01089 | |
| Domain | Connexin_CS | 5.16e-03 | 20 | 101 | 2 | IPR017990 | |
| Domain | CNX | 5.16e-03 | 20 | 101 | 2 | SM00037 | |
| Domain | RHOD | 6.23e-03 | 22 | 101 | 2 | SM00450 | |
| Pubmed | RELCH RBM15 BCAS2 PKP4 DUSP4 DUSP5 RCN2 KRI1 PSMD2 CLPX CDC14B OPA1 NEFL NCOR1 PI4KA MTM1 CTNNA1 | 1.69e-08 | 1049 | 105 | 17 | 27880917 | |
| Pubmed | CUL3 USP13 XRN2 PKP4 KDM3B GON4L CLPX ARHGEF40 ANAPC2 CDK5RAP1 PLXNB1 | 4.54e-06 | 650 | 105 | 11 | 38777146 | |
| Pubmed | 4.75e-06 | 653 | 105 | 11 | 33742100 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 6.82e-06 | 231 | 105 | 7 | 16452087 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19923902 | ||
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 9.03e-06 | 2 | 105 | 2 | 21502810 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25808902 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11207030 | ||
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 9.03e-06 | 2 | 105 | 2 | 18547142 | |
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 9.03e-06 | 2 | 105 | 2 | 3123997 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11498050 | ||
| Pubmed | Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response. | 9.03e-06 | 2 | 105 | 2 | 22147914 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26518330 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12089344 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8557705 | ||
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 9.03e-06 | 2 | 105 | 2 | 11032406 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21135508 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32484592 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19594327 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 9.03e-06 | 2 | 105 | 2 | 26297049 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15051713 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25479464 | ||
| Pubmed | GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. | 9.03e-06 | 2 | 105 | 2 | 12601092 | |
| Pubmed | 2.11e-05 | 18 | 105 | 3 | 18985723 | ||
| Pubmed | RBM15 XRN2 PKP4 ARHGAP35 CLPX ECPAS NEFL ARHGEF40 PIK3R2 KAZN CTNNA1 ARAP1 | 2.15e-05 | 916 | 105 | 12 | 32203420 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL3 NCOA3 RBM15 XRN2 HIRIP3 KDM3B BAZ1B ARHGAP35 ECPAS NCOR1 CTNNA1 | 2.31e-05 | 774 | 105 | 11 | 15302935 |
| Pubmed | Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. | 2.70e-05 | 3 | 105 | 2 | 21262768 | |
| Pubmed | Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription. | 2.70e-05 | 3 | 105 | 2 | 22355704 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12522556 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 27785460 | ||
| Pubmed | High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma. | 2.70e-05 | 3 | 105 | 2 | 32276436 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26343497 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 2574001 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 35296664 | ||
| Pubmed | CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes. | 2.70e-05 | 3 | 105 | 2 | 19129509 | |
| Pubmed | Cdc14A and Cdc14B Redundantly Regulate DNA Double-Strand Break Repair. | 2.70e-05 | 3 | 105 | 2 | 26283732 | |
| Pubmed | Identification of the primary gene defect at the cytochrome P450 CYP2D locus. | 2.70e-05 | 3 | 105 | 2 | 1978251 | |
| Pubmed | 3.36e-05 | 529 | 105 | 9 | 14621295 | ||
| Pubmed | 3.42e-05 | 21 | 105 | 3 | 25708312 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 10620012 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 22505611 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 31944090 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 32341029 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 35420656 | ||
| Pubmed | CDC14A phosphatase is essential for hearing and male fertility in mouse and human. | 5.40e-05 | 4 | 105 | 2 | 29293958 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 22879594 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 24308939 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 21571647 | ||
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 5.40e-05 | 4 | 105 | 2 | 20003447 | |
| Pubmed | 8.04e-05 | 234 | 105 | 6 | 36243803 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 25584796 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 10803578 | ||
| Pubmed | Pericyte dynamics in the mouse germinal matrix angiogenesis. | 8.97e-05 | 5 | 105 | 2 | 35506590 | |
| Pubmed | CUL3 TRIM15 RBM15 HIRIP3 BCAS2 BAZ1B PSMD2 ECPAS PI4KA PRICKLE2 | 9.79e-05 | 754 | 105 | 10 | 35906200 | |
| Pubmed | 1.09e-04 | 81 | 105 | 4 | 22723691 | ||
| Pubmed | 1.34e-04 | 634 | 105 | 9 | 34591612 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 16373399 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 30482882 | ||
| Pubmed | Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. | 1.34e-04 | 6 | 105 | 2 | 18829436 | |
| Pubmed | Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. | 1.34e-04 | 6 | 105 | 2 | 18602983 | |
| Pubmed | Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A. | 1.34e-04 | 6 | 105 | 2 | 26320660 | |
| Pubmed | Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. | 1.34e-04 | 6 | 105 | 2 | 12171760 | |
| Pubmed | Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation. | 1.34e-04 | 6 | 105 | 2 | 28807996 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 20848605 | ||
| Pubmed | The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling. | 1.34e-04 | 6 | 105 | 2 | 25551360 | |
| Pubmed | CUL3 NCOA3 PKP4 GRIN2B OPA1 NEFL NCOR1 LZTS1 ICAM5 PI4KA CTNNA1 | 1.62e-04 | 963 | 105 | 11 | 28671696 | |
| Pubmed | 1.71e-04 | 91 | 105 | 4 | 22610502 | ||
| Pubmed | NCOA3 RBM15 XRN2 BCAS2 RCN2 KRI1 BAZ1B PSMD2 CLPX ANAPC2 CDH18 | 1.74e-04 | 971 | 105 | 11 | 33306668 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DUSP4 DUSP5 RCN2 KRI1 PSMD2 ECPAS OPA1 DNAAF5 THOP1 MTM1 CTNNA1 | 1.78e-04 | 974 | 105 | 11 | 28675297 |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 16059920 | ||
| Pubmed | S1P1 inhibits sprouting angiogenesis during vascular development. | 1.88e-04 | 7 | 105 | 2 | 22951644 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 24113184 | ||
| Pubmed | The GTPase-deficient Rnd proteins are stabilized by their effectors. | 1.88e-04 | 7 | 105 | 2 | 22807448 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 15788656 | ||
| Pubmed | Effects of infection of MRSA on the expression and activity of renal cytochrome P450s in mice. | 1.88e-04 | 7 | 105 | 2 | 30944282 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 20691046 | ||
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 1.94e-04 | 94 | 105 | 4 | 23431145 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.17e-04 | 281 | 105 | 6 | 28706196 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 16188938 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 23756480 | ||
| Pubmed | Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. | 2.50e-04 | 8 | 105 | 2 | 19567891 | |
| Pubmed | Expression of catenins during mouse embryonic development and in adult tissues. | 3.21e-04 | 9 | 105 | 2 | 8821035 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 21144999 | ||
| Pubmed | TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. | 3.21e-04 | 9 | 105 | 2 | 23142077 | |
| Pubmed | Msx1 is expressed in retina endothelial cells at artery branching sites. | 3.21e-04 | 9 | 105 | 2 | 23213427 | |
| Pubmed | Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro. | 3.21e-04 | 9 | 105 | 2 | 23320101 | |
| Pubmed | Genome-wide association study of smoking initiation and current smoking. | 3.21e-04 | 9 | 105 | 2 | 19268276 | |
| Pubmed | A CNS-specific hypomorphic Pdgfr-beta mutant model of diabetic retinopathy. | 3.21e-04 | 9 | 105 | 2 | 23633653 | |
| Pubmed | Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice. | 3.21e-04 | 9 | 105 | 2 | 15579434 | |
| Pubmed | BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. | 3.21e-04 | 9 | 105 | 2 | 20091777 | |
| Pubmed | Role of the Wilms' tumor suppressor gene Wt1 in pancreatic development. | 3.21e-04 | 9 | 105 | 2 | 29708625 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 7720210 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 3.25e-04 | 303 | 105 | 6 | 25056061 | |
| Pubmed | CUL3 PKP4 PSMD2 GJC2 GRIN2B ARHGAP35 OPA1 NEFL LZTS1 ICAM5 PI4KA PRICKLE2 CTNNA1 | 3.81e-04 | 1431 | 105 | 13 | 37142655 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 21577200 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 4.00e-04 | 10 | 105 | 2 | 25303530 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 22969705 | ||
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 15001550 | ||
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 22513384 | ||
| Pubmed | 4.19e-04 | 48 | 105 | 3 | 30938680 | ||
| GeneFamily | Cadherin related | 3.96e-05 | 17 | 72 | 3 | 24 | |
| GeneFamily | CD molecules|5'-nucleotidases | 3.24e-04 | 7 | 72 | 2 | 1042 | |
| GeneFamily | MAP kinase phosphatases | 8.40e-04 | 11 | 72 | 2 | 895 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.19e-03 | 13 | 72 | 2 | 1186 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.56e-03 | 19 | 72 | 2 | 563 | |
| GeneFamily | CD molecules|Mucins | 3.13e-03 | 21 | 72 | 2 | 648 | |
| GeneFamily | Gap junction proteins | 3.43e-03 | 22 | 72 | 2 | 314 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-07 | 182 | 105 | 7 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-07 | 182 | 105 | 7 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.32e-07 | 189 | 105 | 7 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.32e-07 | 189 | 105 | 7 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-06 | 184 | 105 | 6 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-06 | 184 | 105 | 6 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.96e-06 | 190 | 105 | 6 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-06 | 194 | 105 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.18e-05 | 125 | 105 | 5 | c82b4bddc98b2a2d2ee00c1392df86f9735c0623 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 70 | 105 | 4 | 986c7a1002a4ffd3a246495bedde2997ffdc2c9d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 70 | 105 | 4 | c0330216305491d7d57cdbea0ae3cb8e9092c8e3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 70 | 105 | 4 | 86dde790fcdaec2095e2256463953077811145d2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 70 | 105 | 4 | e604660b2efbc03e21806dcaecf7a72321673ae2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.54e-05 | 157 | 105 | 5 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 161 | 105 | 5 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.23e-05 | 163 | 105 | 5 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.88e-05 | 168 | 105 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 170 | 105 | 5 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 170 | 105 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.46e-05 | 172 | 105 | 5 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 173 | 105 | 5 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 173 | 105 | 5 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 174 | 105 | 5 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 174 | 105 | 5 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-05 | 177 | 105 | 5 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-05 | 178 | 105 | 5 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-05 | 178 | 105 | 5 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.60e-05 | 179 | 105 | 5 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 6.60e-05 | 179 | 105 | 5 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 6.60e-05 | 179 | 105 | 5 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 180 | 105 | 5 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 180 | 105 | 5 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 7.71e-05 | 185 | 105 | 5 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-05 | 186 | 105 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.53e-05 | 189 | 105 | 5 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.74e-05 | 190 | 105 | 5 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.74e-05 | 190 | 105 | 5 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 8.96e-05 | 191 | 105 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 8.96e-05 | 191 | 105 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.18e-05 | 192 | 105 | 5 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.64e-05 | 194 | 105 | 5 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.87e-05 | 195 | 105 | 5 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 9.87e-05 | 195 | 105 | 5 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 196 | 105 | 5 | ef650ff106a76c1e926e13c7f002fbc452cc48ae | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 105 | 5 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 105 | 5 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 105 | 5 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 105 | 5 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 105 | 5 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 105 | 5 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 105 | 5 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 200 | 105 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| Drug | 3-amino-2-butanone | 2.03e-06 | 46 | 103 | 5 | CID004472117 | |
| Drug | hydroxynortriptyline | 4.95e-06 | 8 | 103 | 3 | CID005352542 | |
| Drug | CP-101,606 | 7.41e-06 | 9 | 103 | 3 | CID000219101 | |
| Drug | E-10 | 1.65e-05 | 34 | 103 | 4 | CID006452259 | |
| Drug | cupreidine | 2.03e-05 | 2 | 103 | 2 | CID000051196 | |
| Drug | 3-methoxyphenethylamine | 2.03e-05 | 2 | 103 | 2 | CID000074866 | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 5518_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 6265_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 5332_UP | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 6552_UP | |
| Drug | clozapine | 3.52e-05 | 274 | 103 | 8 | CID000002818 | |
| Drug | AC1L1B1W | 4.00e-05 | 84 | 103 | 5 | CID000001248 | |
| Drug | GW 6471 | 4.82e-05 | 16 | 103 | 3 | ctd:C449302 | |
| Drug | pregnanolone | 5.57e-05 | 90 | 103 | 5 | CID000031402 | |
| Drug | 1q66 | 5.84e-05 | 17 | 103 | 3 | CID006323390 | |
| Drug | 2,4,6-trimethylbenzaldoxime | 6.06e-05 | 3 | 103 | 2 | CID000283782 | |
| Drug | O-demethyl encainide | 6.06e-05 | 3 | 103 | 2 | CID000054736 | |
| Drug | chlorpromazine N-oxide | 6.06e-05 | 3 | 103 | 2 | CID000443037 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.51e-07 | 49 | 99 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | solanidine measurement | 6.66e-05 | 4 | 99 | 2 | EFO_0800966 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 2.03e-04 | 34 | 99 | 3 | DOID:9952 (is_marker_for) | |
| Disease | vascular dementia (is_marker_for) | 6.01e-04 | 11 | 99 | 2 | DOID:8725 (is_marker_for) | |
| Disease | depressive disorder (biomarker_via_orthology) | 7.19e-04 | 52 | 99 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | Schizophrenia | GABRB1 GABRD CYP2D6 GRIN2B OPA1 NEFL PI4KA APOL4 AUTS2 GABBR1 | 7.73e-04 | 883 | 99 | 10 | C0036341 |
| Disease | microglial activation measurement | 1.04e-03 | 59 | 99 | 3 | EFO_0010940 | |
| Disease | biological sex | 1.09e-03 | 230 | 99 | 5 | PATO_0000047 | |
| Disease | Myopia | 1.14e-03 | 15 | 99 | 2 | C0027092 | |
| Disease | Alpha ketoglutarate measurement | 1.30e-03 | 16 | 99 | 2 | EFO_0010457 | |
| Disease | Malignant neoplasm of liver | 1.36e-03 | 142 | 99 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.36e-03 | 142 | 99 | 4 | C0023903 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | alcohol drinking | 2.59e-03 | 81 | 99 | 3 | EFO_0004329 | |
| Disease | Epilepsy, Cryptogenic | 2.68e-03 | 82 | 99 | 3 | C0086237 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.68e-03 | 82 | 99 | 3 | EFO_0005658 | |
| Disease | Awakening Epilepsy | 2.68e-03 | 82 | 99 | 3 | C0751111 | |
| Disease | Aura | 2.68e-03 | 82 | 99 | 3 | C0236018 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.93e-03 | 24 | 99 | 2 | DOID:12894 (is_marker_for) | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 2.93e-03 | 24 | 99 | 2 | EFO_0003761, EFO_0005658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLGIRDPRSEYDRT | 1051 | Q99569 | |
| RYRADTLGELDLERA | 51 | Q86TX2 | |
| DYSELDPERFRREEL | 296 | F5H4B4 | |
| REDALRYTLDFLVPA | 41 | Q8TER5 | |
| DPELEGELDSRYARR | 196 | Q9UJX6 | |
| ERRYSTVFLALDRDP | 106 | Q9UKL4 | |
| LRVVSDREEPEAAYR | 1966 | Q6UVK1 | |
| LTPRELEIRRREDEY | 221 | O76031 | |
| VNRRLRELYPDSEDV | 106 | Q9BXI3 | |
| VRVAELPREEADALY | 66 | Q9BPW4 | |
| RRDPQDDVYLDITDR | 41 | O60729 | |
| PERARLYEDRRSSAL | 401 | Q96Q27 | |
| EEEDYEVAGLRLRPR | 1271 | Q9UIG0 | |
| LPLYEVDDLRDAFRT | 181 | Q9GZX7 | |
| PEYTRTLRVLEDRAL | 161 | Q3MIX3 | |
| DITDRLRFAILYSRP | 21 | A4D256 | |
| VARPLDREELDHYIL | 1481 | Q9H251 | |
| LREALLDESRPLFER | 161 | Q9BU89 | |
| PLGERRSDYDREALL | 31 | Q14257 | |
| LLYRDRDRDLYPDSD | 571 | Q96T37 | |
| AREQYRALRPDLADK | 46 | Q8TCD5 | |
| LPRYSFRRLDTRDVE | 271 | Q99571 | |
| EAPYSREEERQRLSD | 436 | Q7L1V2 | |
| ELLESGRELPRLRDY | 116 | Q9P260 | |
| ALREQERLRLYTADP | 191 | Q8WTU0 | |
| ERLRLYTADPLDREA | 196 | Q8WTU0 | |
| SPLARRVDRVAIYEE | 14396 | Q8WXI7 | |
| ERPLDRESRAEYNIT | 406 | Q9Y5F0 | |
| LRLAIEDYRDAEAGR | 501 | Q674X7 | |
| GELYRRTLDSDEERP | 521 | Q9BW71 | |
| SSLAYEERPRRCRDE | 291 | Q9Y250 | |
| PLLYEEALRDEEERA | 301 | O15481 | |
| HRRLYDDRNEPVLRL | 271 | Q8N387 | |
| YEEPPEQLRELSRER | 281 | Q99795 | |
| PENRRRYEAEITALE | 46 | Q9NVR5 | |
| PDYSLVVRAAERARA | 331 | Q5T442 | |
| LEDVNSRRDILPDYE | 196 | Q9UBS5 | |
| EHRNRLLADIRDYRP | 176 | Q53G44 | |
| RYLLLLAAGDPREEV | 516 | Q5VYK3 | |
| DNRLLREDVEYRPLT | 1736 | O43157 | |
| ELRVLYAPRLDDSDC | 401 | Q9UMF0 | |
| TPRLYEADRSFRDRE | 1106 | Q8WXX7 | |
| DVAYRDPSLRDEILE | 141 | P42356 | |
| PVEYLLDRELRFLSD | 136 | Q7LBC6 | |
| PELDEGERFLRDYIL | 231 | Q8N9T8 | |
| VDRLLKGYDIRLRPD | 41 | P18505 | |
| RARLRPIDADTIDIY | 416 | O14764 | |
| EELIFRYLPDELSDR | 506 | Q1L5Z9 | |
| LDPLYRELERIQADE | 671 | Q8IVL5 | |
| LNAARYRDEDPRKLL | 141 | Q9NPH5 | |
| ERPLDRESRAEYNIT | 406 | Q9Y5F1 | |
| DRERDPATYDLLVEA | 731 | Q6V1P9 | |
| LKDRPPLRAREDYDQ | 711 | Q7Z3G6 | |
| NYPRLRELDRNELFE | 581 | O60313 | |
| ALYPFRRERPEDLEL | 11 | O00459 | |
| RAPALLEAARARYES | 11 | Q8N414 | |
| AYDELLPALERALRE | 356 | A8MY62 | |
| FSEERFRPSLEERLE | 296 | P35221 | |
| EYDDPRFLRLLDLAQ | 196 | P10635 | |
| TSEQYELRFRLLDPR | 236 | Q9BVV2 | |
| EGLIEREYLARTPED | 746 | Q13618 | |
| SREARYDPSLLDVRL | 56 | P35219 | |
| REPTRVAELYEEELR | 146 | P17661 | |
| LSLDDSYVERRRAPL | 3931 | Q8TDW7 | |
| IDSIEDRYPRNLTER | 126 | Q13158 | |
| LYDEDILERDPLREQ | 1611 | Q3T8J9 | |
| DPRRELEAEIYRLGS | 636 | Q7Z591 | |
| EPRTLAAAKALRDRY | 36 | K9M1U5 | |
| LRNPSAAEELKYRRD | 676 | Q13634 | |
| RYELDRDLNRLPQDL | 91 | Q9H293 | |
| RPVRYAIDRESDLDQ | 426 | Q9UJ99 | |
| YRELLVHLDDPERAI | 791 | Q86Y56 | |
| IDDRLPTFRDRLVFL | 146 | O14815 | |
| IVYDERSPRAESLRE | 106 | Q13115 | |
| LPADSRKEDEYRRNI | 216 | Q8WWT9 | |
| SARYVLPDEAARARL | 61 | Q16690 | |
| QRYLESVRPLLDDEE | 186 | Q92523 | |
| SPERLASYRRELELR | 401 | Q86XP0 | |
| RSAPEDLRLLFYDEV | 1026 | Q8N1F8 | |
| KDTSLYRPALEELRR | 66 | Q13200 | |
| EYLLRLASTPDLRRF | 316 | Q8TDN2 | |
| RERIAAASSDLYLRP | 1726 | O75376 | |
| SRDDDLLLPYPRARA | 31 | Q9UK23 | |
| ALLRYLLDRDDPSDA | 736 | Q9Y6Q9 | |
| AAAALVEEETRRYRP | 31 | O75934 | |
| PYETDEDPRRRNILR | 1206 | Q9NRY4 | |
| DLLARDFERLGRLPY | 856 | Q96P48 | |
| EDLAREPLAEIRALY | 296 | Q9GZS9 | |
| AEFLAYLLDPRTRRE | 226 | Q8NET6 | |
| DAYRDLPRLLAVAES | 206 | Q96SZ6 | |
| EYDDPRFLRLLDLAQ | 196 | A0A087X1C5 | |
| RLEPRPLAILEDYAD | 96 | Q7M4L6 | |
| LDPELDRHRYERKIS | 1381 | Q8N2C7 | |
| LLVVPYRASDDDLRR | 201 | Q13496 | |
| CEILPEERRRAELDY | 371 | Q15813 | |
| EAIQPYRDRLRSRLE | 121 | Q9C019 | |
| RRLRAALEEVYPDLT | 656 | Q9H0D6 | |
| EDGLLRPELRERVSY | 196 | Q9BY07 | |
| PYKREEEALEERRLS | 781 | Q9P0L9 | |
| LERDYGLRPSALARL | 101 | C9JI98 | |
| IDLLYPTEDRNDRLR | 241 | Q9NRG4 | |
| KDSLRPEAARYLERL | 131 | P52888 | |
| AYELTRREAEANRRP | 516 | Q92995 | |
| EFDEIELAYRRRPPR | 1101 | Q13224 | |
| PSRYREALEEARALR | 291 | Q99608 | |
| EPSRFRALYEQEIRD | 131 | P07196 |